COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus

Coronavirus Guidance for NIH Applicants and Grantees: https://grants.nih.gov/grants/natural_disasters/corona-virus.htm

Dr. Aruna Behera

Dr. Aruna Behera

Scientific Review Officer



Biography

Division:
Division of Translational and Clinical Sciences DTCS
IRG:
Musculoskeletal, Oral and Skin Sciences MOSS
Study Section:
Skeletal Biology Development and Disease SBDD

Dr. Aruna Behera received her Ph.D. in cell and molecular biology from Delhi University, India, and did her postdoctoral training at the Division of Allergy and Immunology, University of South Florida, where she examined the molecular pathogenesis of respiratory syncytial virus (RSV) infection. Her research led to multiple U.S. patents. She then moved to Tufts Medical School as a faculty member and continued to study RSV pathogenesis and expanded her research to examine molecular pathogenesis of Lyme disease and host-pathogen interaction. Her research was supported by funding from private foundations including the American Lung Association. Before joining CSR, she was a senior scientist at Boehringer Ingelheim Pharmaceuticals Inc. in Connecticut, where her research centered on discovery and design of small molecule inhibitors and biologics for treatment of immunological diseases including rheumatoid arthritis, multiple sclerosis and psoriasis.